Your browser doesn't support javascript.
loading
ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study.
Iivanainen, Sanna; Ravichandra, Ravi; Jekunen, Antti; Arokoski, Reetta; Mentu, Santeri; Lang, Laura; Ekström, Jussi; Virtanen, Henri; Kataja, Vesa; Koivunen, Jussi P.
Afiliación
  • Iivanainen S; Department of Oncology and Radiotherapy, Oulu University Hospital and MRC Oulu, P.B. 22, 90029, Oulu, Finland.
  • Ravichandra R; Department of Oncology and Radiotherapy, Vaasa Central Hospital, Vaasa, Finland.
  • Jekunen A; Department of Oncology and Radiotherapy, Vaasa Central Hospital, Vaasa, Finland.
  • Arokoski R; Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.
  • Mentu S; Kaiku Health Oy, Helsinki, Finland.
  • Lang L; Kaiku Health Oy, Helsinki, Finland.
  • Ekström J; Kaiku Health Oy, Helsinki, Finland.
  • Virtanen H; Kaiku Health Oy, Helsinki, Finland.
  • Kataja V; Kaiku Health Oy, Helsinki, Finland.
  • Koivunen JP; Kaiku Health Oy, Helsinki, Finland.
J Cancer Res Clin Oncol ; 149(10): 6875-6882, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36809503
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Finlandia